All News

Transition care may improve diabetes outcomes, according to a study presented at the American Diabetes Association’s 77th Scientific Sessions.

The guide seeks to provide health care professionals with reference information on the science and regulation underpinning biosimilar use.

Top news of the day from across the healthcare landscape.

New biosensor can detect methotrexate, theophylline, and quinine in the blood.

Top news of the day from across the health care landscape.

American Diabetes Association’s 77th Scientific Sessions highlight benefits of glucose monitoring.

Over the years, a number of landmark clinical studies on smoking cessation pharmacotherapy have been published, shaping how we treat people today. Here are 5 of those that every pharmacist should know:

Taking advantage of all the value that nonpharmacy organizations have to offer.

REMOVAL trial results presented at the American Diabetes Association’s 77th Scientific Sessions.

The FDA recommends a 200-mg dose of pembrolizumab every 3 weeks, but researchers disagree.

Another state passes legislation to increase uptake of biosimilars.

Taking steps to improve customer satisfaction may increase oncology revenue for manufacturers.

HIV/AIDS is the number 1 killer among women of reproductive age.

Patients with metabolically healthy obesity have a 50% increased risk of coronary heart disease.

Agents fight cancer by temporarily loosening DNA, increasing the expression of tumor suppressors, and making the tumor more vulnerable.

Powder formulation of HIV drug receives FDA approval.

A look at the top stories in pharmacy last week.

Ritonavir is indicated in combination with other antiretroviral agents for the treatment of pediatric patients with HIV-1.

Survey methods may lead to varying responses to questions related to drug use.

Filgotinib may offer new option for patients with rheumatoid arthritis who have an inadequate response to methotrexate.

Results of the ODYSSEY study presented at the American Diabetes Association’s 77th Scientific Sessions.

Top news of the day from across the healthcare landscape.

Sotagliflozin effective in treating patients with type 1 diabetes.

Findings presented at ADA conference highlight effiacy of insulin glargine/lixisenatide combination.

Top news of the day from across the health care landscape.

Use of natural, herbal, vitamin, and traditional cures available in grocery stores, gas stations, drugstores, health food stores, and from the Internet continues to grow.

Patients who switched to insulin glargine were 57% less likely to experience hypoglycemia.

Two-way text messaging system either maintained or improved A1C levels for teens with type 1 diabetes.

Top articles of the week from The American Journal of Pharmacy Benefits.